Home China's First Non-Invasive EEG-Based Integrated Therapy for Spinal Cord Injury Successfully Tested in Shanghai

China's First Non-Invasive EEG-Based Integrated Therapy for Spinal Cord Injury Successfully Tested in Shanghai

Mar 24, 2026 23:33 CST Updated 23:33
Neuracle

Developer and Manufacturer of Brain-Computer Interface Systems and Related Equipment

Beijing News Shell Finance Reporter Yu Jinmin reported on March 24 that a patient, Mr. Ye, who had been paralyzed for six months due to thoracic spinal cord injury, recently achieved standing and walking for the first time in the ward of Tongji Hospital affiliated with Tongji University by consciously controlling his movements.

Spinal cord injury is a global medical challenge. In the past two decades, the treatment of spinal cord injuries has focused on technologies such as stem cell transplantation, spinal cord electrical stimulation, brain-computer interfaces, brain-spinal interfaces, and the development of new drugs for nerve regeneration. Professor Cheng Liming, the academic leader of orthopedics at Tongji Hospital affiliated with Tongji University, led his team to complete the first non-invasive brain-computer interface, spinal cord electrical stimulation, and lower limb exoskeleton in China.RobotThe Fusion Treatment of Three Cutting-Edge Technologies.

It is reported that the EEG technology provided by Neuracle Technology (Shanghai) Co., Ltd. was used in this trial to convert the patient's intention to control movement into electrical signals, which were then transmitted to the Chengtian exoskeleton robot. Meanwhile, PINS Medical’s spinal cord stimulation technology not only helped the patient generate active joint flexion and extension movements but also transmitted feedback data to the exoskeleton robot.

The reporter of Shell Finance noticed that as early as March 13, according to the announcement released on the official website of the National Medical Products Administration, the National Medical Products Administration approved the innovative product registration application of Neuracle Technology (Shanghai) Co., Ltd. for its implantable brain-computer interface hand motor function compensation system, achieving the world's first market launch of brain-computer interface medical devices.

Professor Cheng Liming told reporters that this is the first time to achieve real walking by non-invasively collecting patients' EEG signals, amplifying them externally, and reprogramming them with the help of an exoskeleton robot device. In the future, the team will continue to integrate new therapies such as stem cells, intelligent responsive novel biomaterials, neuroregenerative small-molecule AI drugs, and mindfulness interventions to promote nerve regeneration and neural circuit reconstruction, pushing for a truly "perfect repair" of spinal cord injuries.

Proofread by Chunyin Fu